Skip to main content

Table 1 Indications to TAVI

From: Percutaneous treatment of patients with heart diseases: selection, guidance and follow-up. A review

CLINICAL INDICATIONS

CLINICAL CONTRAINDICATIONS

ECHOCARDIOGRAPHIC INDICATIONS

ECHOCARDIOGRAPHIC CONTRAINDICATIONS

Severe AS with Symptoms

and

High Risk for Surgery

Life Expectancy < 1 Year

Severe Respiratory Insufficiency for Transapical Approach

Previous Surgery of the Left Ventricle using a Patch for Transapical Approach

Severe AS

18 < Aortic Annulus < 25 mm for SAPIEN Valve;

20 < Aortic Annulus < 27 mm for CORE Valve

Aortic Tubular Junction < 45 mm for CORE Valve

Bicuspid Aortic Valve

Subaortic Stenosis

Height of coronary ostia from the base of aortic valve leaflets < 10 mm

Asymmetric Heavy Aortic Valvular Calcification

Intracardiac Thrombus

Mitral Regurgitation > 2+

Left Ventricular Ejection Fraction < 20%

Severe Left Ventricular Hypertrophy (< 1,7 cm)

Bulky Atherosclerosis of the Ascending Aorta and Arch for Transfemoral Approach

Calcified Pericardium for Transapical Approach